Research programme: interleukin 12 variants - GenOdyssee

Drug Profile

Research programme: interleukin 12 variants - GenOdyssee

Alternative Names: GOIL-12s; IL-12 variants - GenOdyssee; interleukin 12 variants - GenOdyssee

Latest Information Update: 16 Jul 2016

Price : $50

At a glance

  • Originator GenOdyssee
  • Class Adjuvants; Interleukins
  • Mechanism of Action Interleukin 12 stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Bacterial infections; Cancer; Parasitic infections; Viral infections

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Viral-infections in France
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Parasitic-infections in France
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in France
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top